Desmethylanethol trithione (ADT-OH) is a synthetic H2S-releasing compound. Research demonstrates its ability to inhibit the tPA-enhanced Akt/VEGF/MMP-9 pathway, reducing hemorrhage and improving outcomes in murine stroke models, positioning it as a valuable tool for studying cerebrovascular protection and tPA adjunct therapy.